Previous studies have shown that SLC2A3 could be directly regulated by miR-106a in glioblastoma (Dai et al., 2013), as well as by miR-195-5p in bladder cancer (Fei et al., 2012). The gene discussed is SLC2A3; the disease is glioblastoma.